BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20490336)

  • 1. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.
    Du S; Rashidi HH; Le DT; Kipps TJ; Broome HE; Wang HY
    Int J Clin Exp Pathol; 2010 Apr; 3(4):448-57. PubMed ID: 20490336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components.
    Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN
    Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP; Sotlar K; Sperr WR; Valent P
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.
    Jawhar M; Schwaab J; Schnittger S; Sotlar K; Horny HP; Metzgeroth G; Müller N; Schneider S; Naumann N; Walz C; Haferlach T; Valent P; Hofmann WK; Cross NC; Fabarius A; Reiter A
    Leukemia; 2015 May; 29(5):1115-22. PubMed ID: 25567135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
    Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
    Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
    Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
    Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
    Damaj G; Joris M; Chandesris O; Hanssens K; Soucie E; Canioni D; Kolb B; Durieu I; Gyan E; Livideanu C; Chèze S; Diouf M; Garidi R; Georgin-Lavialle S; Asnafi V; Lhermitte L; Lavigne C; Launay D; Arock M; Lortholary O; Dubreuil P; Hermine O
    PLoS One; 2014; 9(1):e85362. PubMed ID: 24465546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).
    Valent P; Arock M; Akin C; Sperr WR; Reiter A; Sotlar K; Hartmann K; George TI; Brockow K; Kluin-Nelemans HC; Gotlib J; Metcalfe DD; Horny HP
    Blood; 2010 Aug; 116(5):850-1. PubMed ID: 20688965
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
    Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J
    J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.
    Gülen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny HP; Hägglund H
    Med Oncol; 2012 Dec; 29(5):3540-6. PubMed ID: 22661384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of bone marrow mastocytosis associated with multiple myeloma.
    Hagen W; Schwarzmeier J; Walchshofer S; Zojer N; Chott A; Sillaber C; Ackermann J; Simonitsch I; Bühring HJ; Drach J; Lechner K; Horny HP; Valent P
    Ann Hematol; 1998; 76(3-4):167-74. PubMed ID: 9619735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
    Sperr WR; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Feb; 127(2):140-2. PubMed ID: 11919425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.
    Stoecker MM; Wang E
    Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic mastocytosis with plasma cell dyscrasia: report of a case.
    Pullarkat ST; Sedarat F; Paquette R; Said J
    Leuk Res; 2008 Jul; 32(7):1160-3. PubMed ID: 18061667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
    Valent P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.